BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25461314)

  • 41. In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
    Cabrera M; Mastandrea I; Otero G; Cerecetto H; González M
    Bioorg Med Chem; 2016 Apr; 24(8):1665-74. PubMed ID: 26970663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ester of Quinoxaline-7-carboxylate 1,4-di-N-oxide as Apoptosis Inductors in K-562 Cell Line: An in vitro, QSAR and DFT Study.
    Rivera G; Andrade-Ochoa S; Romero MSO; Palos I; Monge A; Sanchez-Torres LE
    Anticancer Agents Med Chem; 2017; 17(5):682-691. PubMed ID: 27396382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and anti-proliferative activity of fluoro-substituted chalcones.
    Burmaoglu S; Algul O; Anıl DA; Gobek A; Duran GG; Ersan RH; Duran N
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3172-3176. PubMed ID: 27217001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chalcone derivatives targeting mitosis: synthesis, evaluation of antitumor activity and lipophilicity.
    Pinto P; Machado CM; Moreira J; Almeida JDP; Silva PMA; Henriques AC; Soares JX; Salvador JAR; Afonso C; Pinto M; Bousbaa H; Cidade H
    Eur J Med Chem; 2019 Dec; 184():111752. PubMed ID: 31610374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of potent heterodimeric antagonists of inhibitor of apoptosis proteins (IAPs) with sustained antitumor activity.
    Perez HL; Chaudhry C; Emanuel SL; Fanslau C; Fargnoli J; Gan J; Kim KS; Lei M; Naglich JG; Traeger SC; Vuppugalla R; Wei DD; Vite GD; Talbott RL; Borzilleri RM
    J Med Chem; 2015 Feb; 58(3):1556-62. PubMed ID: 25584393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-breast cancer activity of heteroaryl chalcone derivatives.
    Solomon VR; Lee H
    Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
    Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of chalcone-amidobenzothiazole conjugates as antimitotic and apoptotic inducing agents.
    Kamal A; Mallareddy A; Suresh P; Shaik TB; Lakshma Nayak V; Kishor C; Shetti RV; Sankara Rao N; Tamboli JR; Ramakrishna S; Addlagatta A
    Bioorg Med Chem; 2012 Jun; 20(11):3480-92. PubMed ID: 22543234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis, and ex vivo anti-drug resistant cervical cancer activity of novel molecularly targeted chalcone derivatives.
    Yang Z; Wang Y; Ablise M; Maimaiti A; Mutalipu Z; Yan T; Liu ZY; Aihaiti A
    Bioorg Chem; 2024 Aug; 149():107498. PubMed ID: 38805911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A potential antitumor agent, (6-amino-1-methyl-5-nitrosouracilato-N3)-triphenylphosphine-gold(I): structural studies and in vivo biological effects against experimental glioma.
    Illán-Cabeza NA; García-García AR; Martínez-Martos JM; Ramírez-Expósito MJ; Peña-Ruiz T; Moreno-Carretero MN
    Eur J Med Chem; 2013 Jun; 64():260-72. PubMed ID: 23644209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chalcone arrests cell cycle progression and induces apoptosis through induction of mitochondrial pathway and inhibition of nuclear factor kappa B signalling in human bladder cancer cells.
    Shen KH; Chang JK; Hsu YL; Kuo PL
    Basic Clin Pharmacol Toxicol; 2007 Oct; 101(4):254-61. PubMed ID: 17845507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination of liquiritin, isoliquiritin and isoliquirigenin induce apoptotic cell death through upregulating p53 and p21 in the A549 non-small cell lung cancer cells.
    Zhou Y; Ho WS
    Oncol Rep; 2014 Jan; 31(1):298-304. PubMed ID: 24247527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aza-isoindolo and isoindolo-azaquinoxaline derivatives with antiproliferative activity.
    Parrino B; Carbone A; Spanò V; Montalbano A; Giallombardo D; Barraja P; Attanzio A; Tesoriere L; Sissi C; Palumbo M; Cirrincione G; Diana P
    Eur J Med Chem; 2015 Apr; 94():367-77. PubMed ID: 25778992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways.
    Ding Z; Parchment RE; LoRusso PM; Zhou JY; Li J; Lawrence TS; Sun Y; Wu GS
    Clin Cancer Res; 2001 Nov; 7(11):3336-42. PubMed ID: 11705845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
    Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L
    Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design and multi-step synthesis of chalcone-polyamine conjugates as potent antiproliferative agents.
    Rioux B; Pouget C; Fidanzi-Dugas C; Gamond A; Laurent A; Semaan J; Pinon A; Champavier Y; Léger DY; Liagre B; Duroux JL; Fagnère C; Sol V
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4354-4357. PubMed ID: 28838697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.
    Mai CW; Yaeghoobi M; Abd-Rahman N; Kang YB; Pichika MR
    Eur J Med Chem; 2014 Apr; 77():378-87. PubMed ID: 24675137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, characterization, and optimization for in vivo delivery of a nonselective isopeptidase inhibitor as new antineoplastic agent.
    Cersosimo U; Sgorbissa A; Foti C; Drioli S; Angelica R; Tomasella A; Picco R; Semrau MS; Storici P; Benedetti F; Berti F; Brancolini C
    J Med Chem; 2015 Feb; 58(4):1691-704. PubMed ID: 25639862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides.
    Grande F; Aiello F; Grazia OD; Brizzi A; Garofalo A; Neamati N
    Bioorg Med Chem; 2007 Jan; 15(1):288-94. PubMed ID: 17085054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs.
    Wang HM; Zhang L; Liu J; Yang ZL; Zhao HY; Yang Y; Shen D; Lu K; Fan ZC; Yao QW; Zhang YM; Teng YO; Peng Y
    Eur J Med Chem; 2015 Mar; 92():439-48. PubMed ID: 25590864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.